Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Polycystic Ovarian Syndrome (PCOS) Biomarker Evaluation Study — Stella

Home/Polycystic Ovarian Syndrome (PCOS)/Polycystic Ovarian Syndrome (PCOS) Biomarker Evaluation Study

View on ClinicalTrials.gov

Recruiting

Back to Polycystic Ovarian Syndrome (PCOS) trials

Polycystic Ovarian Syndrome (PCOS) Biomarker Evaluation Study

Trial locations(1 site)

Germany

Department of Obstetrics and Gynecology, University Erlangen Hospital, Friedrich Alexander University of Erlangen-Nuremberg, Erlangen, Germany, Erlangen

Key details

Sponsor

University Hospital Erlangen

Collaborators

Roche Diagnostics International AG

Enrollment target

~380 participants

Started

January 2023

Primary completion

December 2026

Age range

15 Years – 25 Years

Sex

Female only

Last updated October 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.